Dr. Melanie Shapiro Post doctoral associate Melanie Shaprio has been awarded the prestigious National Institute of Diabetes and Kidney Diseases (NIDDK) K99/R00 award. The project “FcyR Receptor-Mediated Pharmacogenomics of Antibody Therapies in Type 1 Diabetes” is expected to aid in generation of prescription medicine to target subjects with or at-risk…
Image Gallery Puchong, Elise, Matt, Sonali Gbemi & Emerson Elise & Sonali Akash February 28, 2023…
FOCIS 2022 Poster of Distinction Awards Puchong ThirawatananondSelective CD226 Knockout on Regulatory T cells Reduces Diabetes in Female NOD MiceMatt Brown Human CD4+CD25+Regulatory T Cells Deficient of CD226 Demonstrate…
2022 Graduates with Honor Thesis Lindsey SachsMatt BrownJuan Martin Arnoletti…
University of Florida researchers will use a new $5 million grant to develop a “pancreatic islet on a chip” — a platform that will allow them to more efficiently and effectively study Type 1 diabetes and potential treatments for the condition.
Human Atlas of Neonatal Development and Early Life-Immunity (HANDEL-I) The early life events that influence immune system development have implications in the development of a multitude of diseases including type 1 diabetes (T1D). The immune system is actively evolving and integrating dynamic signals from the host’s environment, not…
University of Florida and Kings College London have secured a $3.7 million grant funded by Adaptive Biotechnologies and the Leona M. and Harry B. Helmsley Charitable Trust to profile T cell receptor sequences in Type 1 Diabetes. Congratulations to co-investigators Dr. Todd Brusko and Dr. Mark Peakman!…
The Brusko Lab is currently recruiting a Postdoc to work on our NIH R01 “The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes.”…
The 1-year C-peptide was significantly higher (β-cell preservation) in subjects treated with ATG versus placebo (P = 0.0003) but not in those treated with ATG/GCSF versus placebo (P = 0.031).
The Brusko Lab and collaborators are trying to better understand how genes influence T1D risk…
